1958: Americas Response to Sputnik U.S. Defense budget increased to - - PowerPoint PPT Presentation
1958: Americas Response to Sputnik U.S. Defense budget increased to - - PowerPoint PPT Presentation
1958: Americas Response to Sputnik U.S. Defense budget increased to a peace- time record $74 billion DARPA - Defense Advanced Research Projects Agency National Defense Education Act $3 billion invested in high schools and
- U.S. Defense budget increased to a peace-
time record $74 billion
- DARPA - Defense Advanced Research
Projects Agency
- National Defense Education Act
- $3 billion invested in high schools and
universities throughout the 1960s
- NASA – National Aeronautics and Space
Administration
Source: PC World
1958: America’s Response to Sputnik
1969: “The Eagle has landed.”
Nixon Declares War on Cancer - 1971
Each life is priceless… but in economic terms, over the past two centuries, as much as 50%
- f all economic
growth can be traced to advances in health.
The Value of Health
Worldwide Life Expectancy
Four million years produced an 11-year increase from 20 to 31.
31 72 1900 2018
118 years produced a 41- year increase.
James Carey: Longevity; United Nations Development Program
- Chicken pox
- Diphtheria
- H. influenza-caused
invasive diseases
- Measles
- Pertussis
- Pneumococcal disease
- Polio
- Tetanus
- Typhoid fever
- Yellow fever
- Smallpox
Source: Discovery Fit & Health
Some Major Diseases Now Mostly Controlled
- Vastly improved sanitation
- Development of antibiotics
- Implementation of vaccines
- Progress against heart disease
- Investment in bioscience research
What caused the increase?
The National Cancer Summit 1995
The March of Progress
Milken Family Foundation Cancer Research Awards 1970s/1980s CaP CURE PCF 1993 The MARCH in Washington 1998
Innovation Retreat / NCATS 2011 Partnering For Cures 2009 - current FasterCures 2003 - 2015 NIH Budget Doubles 1998-2003
The March of Progress
Celebration of Science 2012 CDC Conference 2014 21st Century Cures Act 2016 Milken Institute School of Public Health 2014
The March of Progress
The March of Progress
PCF-VA Veterans Health Initiative 2016 - current Future of Health Summit 2017 - current Giving Pledge Learning Session February 2017
Direct Health Care Costs for Treatment of Chronic Illnesses and Indirect Productivity Losses, 2016 ($ Billions)
Equivalent to 19.6% of GDP
Diabetes $526.6 Cardiovascular Conditions $1,461.3 Alzheimers Disease $268.3 Arthritis & Back Pain $843.4 Cancers $281.0 Other Conditions $267.5
Total direct costs = $3.7 trillion
Cost of Chronic Diseases: $3.7 Trillion
Source: The Costs of Obesity in the U.S., Milken Institute, July 30, 2018
Condition
Costs (in $ Millions)
Direct Indirect TOTAL
Alzheimer's or Vascular Dementia $73,572 $32,606 $106,178 Asthma $10,564 $16,234 $26,798 Breast Cancer $5,900 $3,669 $9,569 Chronic Back Pain $38,476 $217,291 $255,768 Colorectal Cancer $6,151 $5,425 $11,576 Congestive Heart Failure $5,201 $2,039 $7,239 Coronary Heart Disease $22,700 $39,315 $62,015 Diabetes Type 2 $120,707 $214,500 $335,208 Dyslipidemia $28,619 † $28,619 End Stage Renal Disease $3,716 †† $3,716 Endometrial Cancer $189 $158 $347 Esophageal Adenocarcinoma $970 $92 $1,061 Gallbladder Cancer $22 $17 $39 Gallbladder Disease $26,863 $27,401 $54,264 Gastric Cardia Adenocarcinoma $1,433 $136 $1,568 Hypertension $29,323 $432,230 $461,553 Liver Cancer $87 $67 $154 Osteoarthritis $86,480 $215,303 $301,783 Ovarian Cancer $1,152 $152 $1,304 Pancreatic Cancer $146 $738 $884 Prostate Cancer $1,983 $13,411 $15,393 Renal Cancer $2,254 $559 $2,813 Stroke $14,148 $14,527 $28,674 $480,654 $1,235,869 $1,716,523
Source: The Costs of Obesity in the U.S., Milken Institute, July 30, 2018
Total Costs of Obesity and Overweight, 2016
We have entered a new Age of Medicine.
- Immunology
- Precision medicine
- Genomics
- Powerful diagnostic tools
When robotic surgery is performed by a certified provider with advanced training and skill …
- Less blood loss, less trauma to the body, less
scarring.
- Hospital stays are shorter and recovery times
much faster.
Source: University of Kentucky HealthCare
Minimally Invasive Robotic Surgery
400,000 robotic surgeries were performed in the U.S. in 2012. The rate of robotic surgeries is increasing 25% per year. By 2020, the global medical robotic system market will reach $18 billion; compound annual growth rate will be 12.7%.
Source: Becker’s ASC Review 7/23/15; 11 Things to Know About Robotic Surgery
Robotic Surgery
- Two highly skilled pathologists
assessing the same slide will agree
- nly about 60% of the time.
- Machine-learning predicted patient
survival times better than the standard practice of pathologists.
Source: Stanford University School of Medicine
Pathologist vs. Computer
Sequencing the Human Genome
2003:
- 13 years
- $3 billion
Today:
- A few hours
- Approaching $1,000
The Origins of Immunotherapy
Reported a major breakthrough in the development of successful gene therapy that for the first time in history harnessed the body's own immune system to shrink tumors.
- Dr. Rosenberg is now chief of
surgery at the National Cancer Institute.
Steven Rosenberg, M.D.
Arie Belldegrun, MD
Commercialization of Rosenberg’s Work
Milken Institute’s Concept to Commercialization
1. University of Utah 2. Columbia University 3. University of Florida 4. Brigham Young University 5. Stanford University 6. University of Pennsylvania 7. University of Washington 8. MIT 9. California Inst. of Technology
- 10. Carnegie Mellon University
PCF Leverage in New Cancer Drugs
Impact of PCF Young Investigators
10 FDA-approved treatments for prostate cancer since 2010.
- Provenge: stimulates tumor immunity
- Xgeva: improves quality of life by reducing side effects
- Jevtana: chemotherapy that kills prostate cancer cells
- Zytiga: reduces testosterone, resulting in longer life
- Xtandi: blocks testosterone’s cancer targets and prolongs life
- Xofigo: results in less medication to control bone pain
- Erleada: treatment for those who fail testosterone reduction
- Zytiga + Prednisone: delays cancer progression by 18 months
- Pembrolizumab: precision immunotherapy for solid tumors
- Xtandi: secondary approval for non-metastatic CRPC
Heritage Provider Network: The Challenge
Heritage Provider Network: The Solution
“Never doubt that a small group of thoughtful, committed citizens can change the world: indeed, it’s the only thing that does.”
- Margaret Mead